Australian Pharmacy Guild takes its case to the public

12 August 2013

Pharmacy patients around Australia are being urged to rally against a shock federal government decision which puts at risk their access to prescription medicines and locally available health care services, says the nation’s Pharmacy Guild.

The Australian government earlier this month announced plans that would save patient hundreds of dollars a year on the cost of prescription medicines as the government speeds up its clawback of the profits chemists make on generic drugs (The Pharma Letter August 2).

A petition has been circulated calling on the federal government to address the very real risk that its recent Pharmaceutical Benefits Scheme (PBS) budget measure may force pharmacies to close their doors or slash important services for the elderly, very young or chronically ill. The risk is particularly high for the more than 1,000 pharmacies in rural and regional areas, and for the 411 Australian towns which have just one pharmacy, the Guild argues.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics